ClinicalTrials.gov record
Completed No phase listed Observational

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

ClinicalTrials.gov ID: NCT02239666

Public ClinicalTrials.gov record NCT02239666. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics

Study identification

NCT ID
NCT02239666
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
AstraZeneca
Industry
Enrollment
899 participants

Conditions and interventions

Interventions

  • NIS Other

Other

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2014
Primary completion
Jan 4, 2017
Completion
Jan 4, 2017
Last update posted
Aug 2, 2017

2014 – 2017

United States locations

U.S. sites
37
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Research Site Birmingham Alabama 35233
Research Site Hot Springs Arkansas 71913
Research Site Rogers Arkansas 72758
Research Site Bakersfield California 93309
Research Site Burbank California 91505
Research Site Irvine California 92697
Research Site Sacramento California 95819
Research Site Aurora Colorado 80045
Research Site Aventura Florida 33180
Research Site Pembroke Pines Florida 33028
Research Site Alpharetta Georgia 30022
Research Site Macon Georgia 31217
Research Site Sandy Springs Georgia 30328
Research Site Carmel Indiana 46032
Research Site Indianapolis Indiana 46256
Research Site Overland Park Kansas 66215
Research Site Louisville Kentucky 40202
Research Site Owensboro Kentucky 42303
Research Site Silver Spring Maryland 20902
Research Site Clarkston Michigan 48346
Research Site St Louis Missouri 63117
Research Site East Windsor New Jersey 08520
Research Site New York New York 10016
Research Site Rochester New York 14618
Research Site Gahanna Ohio 43230
Research Site Warren Ohio 44483
Research Site Portland Oregon 97239
Research Site Philadelphia Pennsylvania 19103
Research Site Pittsburgh Pennsylvania 15213
Research Site Dallas Texas 75246
Research Site Houston Texas 77065
Research Site San Antonio Texas 78229
Research Site West Jordan Utah 84088
Research Site Norfolk Virginia 23502
Research Site Roanoke Virginia 24016
Research Site Seattle Washington 98101
Research Site Bridgeport West Virginia 26330

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02239666, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2017 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02239666 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →